Evidence map›Paper›PMID 31826389›Full record

ArticleKidney research and clinical practice2019

Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center study.

Keun Hoi Park, Jung A Yoon, Hak Soo Kim, Hyosang Kim, Su-Kil Park, Young Hoon Kim, Bumsik Hong, Dalsan You, In Gab Jeong, Chung Hee Baek

Open access · diamondAbstract read
In one paragraph

Article in Kidney research and clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Keun Hoi ParkDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-9256-7378
Jung A YoonDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-6010-8214
Hak Soo KimDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-9258-1057
Hyosang KimDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-8140-9534
Su-Kil ParkDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-7242-7204
Young Hoon KimDepartment of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0003-3840-8426
Bumsik HongDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0003-1991-1229
Dalsan YouDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-8152-847X
In Gab JeongDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0003-4093-832X
Chung Hee BaekDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.ORCID http://orcid.org/0000-0001-7611-2373
Ulsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have recommended a 2- to 5-year waiting time prior to kidney transplantation (KT) in patients with end-stage renal disease (ESRD) and symptomatic renal cell carcinoma (RCC) and no delay for incidental early-stage RCC. Data on Asian KT recipients are unavailable.

methodsThis is a Korean single-center retrospective study on 35 KT recipients with ESRD and RCC. Patients were classified into two groups: early KT (KT performed within 1 year after nephrectomy for RCC, including KT with simultaneous nephrectomy) and delayed KT (KT performed over than 1 year after nephrectomy for RCC). Patient survival, graft survival, and cancer recurrence were compared between both groups.

resultsThere were no statistically significant differences in patient survival (

conclusionPatients with early-stage and asymptomatic RCC do not require a mandatory observational period prior to KT after curative nephrectomy.

Indexed as

End-stage renal diseaseKidney transplantationRecurrenceRenal cell carcinomaSurvival

Identifiers

PMID31826389
PMCPMC6913591
OpenAlexW2995847853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.